As of 2025-10-23, the Fair Value of Rocket Pharmaceuticals Inc (RCKT) is -11.94 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 3.80 USD, the upside of Rocket Pharmaceuticals Inc is -414.11%.
With the market price of 3.80 USD and our fair value calculation, Rocket Pharmaceuticals Inc (RCKT) is not a good investment. Investing in RCKT stocks now will result in a potential loss of 414.11%.
Note: valuation result may not be accurate due to the low predictability of business.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -139.70 | -169.07 | -221.86 | -245.59 | -258.75 | -206.99 |
| YoY growth | -80.79% | -21.02% | -31.22% | -10.70% | -5.35% | -29.82% |
| Market Cap (mil) | 410.02 |
| P/E | |
| Forward P/E |
| EPS | -2.39 |
| Avg earnings growth rate | -29.82% |
| TTM earnings |